In India’s case, it is leveraging its clout as a major supplier of power and telecommunications equipment and active pharmaceutical ingredients, not to mention as a lender to financially troubled Indian firms, to limit the country’s options. By allowing the trade distortions from which China profits to persist – and, indeed, to grow – India is effectively funding this strategy.